Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators
UMass Chan Affiliations
UMass Center for Clinical and Translational ScienceDocument Type
Journal ArticlePublication Date
2017-04-01Keywords
UMCCTS fundingTranslational research
design and analysis
genetic counseling
patient-centered research
Translational Medical Research
Metadata
Show full item recordAbstract
INTRODUCTION: Obtaining informed consent from prospective participants for research studies that include next-generation nucleotide sequencing (NGS) presents significant challenges because of the need to explain all the potential implications of participating, including the possible return of "incidental" findings, in easy-to-understand language. METHODS AND RESULTS: After reviewing the consent processes at other institutions, we decided to supplement the protocol-specific informed consent form with the following: (1) a short pamphlet for the prospective participant that includes a series of questions that she or he is encouraged to ask the investigator, and (2) a more detailed companion guide for investigators to help them develop simple-language answers to the questions. Both documents are available to use or modify. CONCLUSIONS: We propose an approach to obtaining informed consent for NGS studies that encourages discussion of key issues without creating a complex, comprehensive document for participants; it also maximizes investigator flexibility. We also suggest mechanisms to return restricted information to participants.Source
Kost RG, Poppel SM, Coller BS. Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators. Version 2. J Clin Transl Sci. 2017 Apr;1(2):115-120. doi: 10.1017/cts.2016.21. Epub 2017 Feb 7. PMID: 28649453; PMCID: PMC5471895. Link to article on publisher's site
DOI
10.1017/cts.2016.21Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50397PubMed ID
28649453Notes
The authors acknowledge the work of the New England Research Subject Advocacy Group, which was conducted with support from the UMass Center for Clinical and Translational Science and other centers that are part of the the National Center for Advancing Translational Sciences, National Institutes of Health.
Related Resources
ae974a485f413a2113503eed53cd6c53
10.1017/cts.2016.21